(It Doesn’t Really Matter As Long As Patients and Surgeons Stop Buying the Defective Implants!) While it would certainly be nice to have a government that moved swiftly to recall defective drugs and medical devices from the market, we do not live in that world – at least in the […]
Category: Articles
As a Stryker hip implant attorney, I have written previously about our experience with clients who had Stryker hip replacement problems. Most of these clients tell us about conversations with their doctors before surgery in which they were told the Rejuvenate hip was better for them due to their young […]
According to an analysis by the Institute for Safe Medication Practices, Pradaxa drug (Dabigatran) topped the list of direct reports to the FDA for serious adverse drug events in 2011. Pradaxa took the lead with 817 direct reports, followed by Coumadin (Warfarin) with 490 direct reports, Levaquin (Levofloxacin) with 393, […]
It seems sort of nonsensical to blame the victim for his or her condition but that is what medical device maker Stryker appears to be doing in an April Field Safety Notice (FSN). In the United Kingdom, medical device manufacturers are required to report to the MHRA, their version of our […]
With all of the controversy, bad outcomes, and thousands of personal injury lawsuits concerning vaginal mesh, this medical doctor has a novel approach. Dr. John Wei of the University of Michigan suggests using a mid-urethral sling to prevent incontinence, even when the woman is not incontinent! Published June 20, 2012 […]
Even though more than 93,000 patients have been implanted with the now recalled DePuy metal-on-metal hip, the U.S. Food and Drug Administration wants to start a conversation. It seems a little like the proverbial “closing the barn door after the horse has already escaped”. The federal agency will convene a […]
According to a study published June 11, the users of Actos (pioglitazone) or Avandia (rosiglitazone) may face an increased risk of developing macular edema. Published in the Archives of Internal Medicine, British researchers collected data on more than 100,000 patients with type 2 diabetes who were enrolled in the British […]
In its June 4th announcement that it is taking four synthetic vaginal meshes off the market, Ethicon acts like it is in charge of the FDA. First, the division of Johnson & Johnson (J&J) requests it be given 120 days to “cease commercialization” which essentially means allowing the four defective […]
Four mesh products have been recalled that belong to the Gynecare family of polypropylene mesh under the Ethicon division of Johnson & Johnson. In a June 4th letter Ethicon advised the court it was suspending the sale of synthetic vaginal meshes and on page 2 there is a curious note […]
Late last night, June 4th comes news from Bloomberg, that medical device maker, Johnson & Johnson (J&J) plans to stop selling four transvaginal mesh implants in the face of hundreds of lawsuits and more to come. Ethicon, a unit of J&J, told a federal judge in West Virginia that it […]
